{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:55:24Z","timestamp":1787237724312,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.blre.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T02:27:01Z","timestamp":1428287221000},"page":"335-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research"],"prefix":"10.1016","volume":"29","author":[{"given":"Alessandro","family":"Di Minno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Spadarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Scalera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.blre.2015.03.004_bb0005","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/ajg.2009.164","article-title":"Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice","volume":"104","author":"Lanas","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.blre.2015.03.004_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3111\/13696998.2011.571328","article-title":"Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: a systematic review","volume":"14","author":"Parker","year":"2011","journal-title":"J Med Econ"},{"issue":"2","key":"10.1016\/j.blre.2015.03.004_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1160\/TH13-02-0150","article-title":"Gastrointestinal bleeding with the new oral anticoagulants-defining the issues and the management strategies","volume":"110","author":"Desai","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.03.004_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, MI, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"7571","key":"10.1016\/j.blre.2015.03.004_bb0025","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.38947.697558.AE","article-title":"Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case\u2013control study","volume":"333","author":"Hallas","year":"2006","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.blre.2015.03.004_bb0030","first-page":"1433","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"13; 170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2 Suppl","key":"10.1016\/j.blre.2015.03.004_bb0035","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.blre.2015.03.004_bb0040","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.blre.2015.03.004_bb0045","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.amjmed.2005.09.052","article-title":"Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics","volume":"119","author":"Choudhry","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11739-013-0944-8","article-title":"Mannucci PM; REPOSI Investigators. Prophylaxis of venous thromboembolism in elderly patients with multimorbidity","volume":"8","author":"Marcucci","year":"2013","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0055","first-page":"369","article-title":"Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes","volume":"58","author":"Rubin","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.blre.2015.03.004_bb0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.03.004_bb0070","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2012.02.008","article-title":"New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper","volume":"59","author":"De Caterina","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.blre.2015.03.004_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccl.2007.12.010","article-title":"Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly","volume":"26","author":"Jacobs","year":"2008","journal-title":"Cardiol Clin"},{"issue":"5","key":"10.1016\/j.blre.2015.03.004_bb0080","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1160\/TH13-11-0918","article-title":"New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions","volume":"111","author":"Chan","year":"2014","journal-title":"Thromb Haemost"},{"issue":"18","key":"10.1016\/j.blre.2015.03.004_bb0085","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIR.0b013e318290826d","article-title":"Management of patients with atrial fibrillation (compilation of 2006 ACCF\/AHA\/ESC and 2011 ACCF\/AHA\/HRS recommendations): a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"127","author":"Wann","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.blre.2015.03.004_bb0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11739-013-0948-4","article-title":"Laboratory tests during direct oral anticoagulant treatment? No.","volume":"8","author":"Di Minno","year":"2013","journal-title":"Intern Emerg Med"},{"issue":"9921","key":"10.1016\/j.blre.2015.03.004_bb0095","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.03.004_bb0100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-156-10-201205150-00421","article-title":"Oral direct factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis","volume":"156","author":"Neumann","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.blre.2015.03.004_bb0110","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0115","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2015.03.004_bb0120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.blre.2015.03.004_bb0125","doi-asserted-by":"crossref","first-page":"e21447","DOI":"10.1371\/journal.pone.0021447","article-title":"Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case\u2013control study","volume":"6","author":"Schelleman","year":"2011","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.blre.2015.03.004_bb0130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.1996.00440100095011","article-title":"National Consortium of Anticoagulation Clinics. Management and prognosis of life threatening bleeding during warfarin therapy","volume":"156","author":"White","year":"1996","journal-title":"Arch Intern Med"},{"issue":"21","key":"10.1016\/j.blre.2015.03.004_bb0135","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery","volume":"336","author":"Kearon","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2015.03.004_bb0140","first-page":"369","article-title":"Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes","volume":"58","author":"Rubin","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.blre.2015.03.004_bb0145","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archinte.1993.00410130073007","article-title":"Bleeding complications in oral anticoagulant therapy: an analysis of risk factors","volume":"153","author":"Van der Meer","year":"1993","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.blre.2015.03.004_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(93)90285-W","article-title":"Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention","volume":"95","author":"Landefeld","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/gut.36.4.483","article-title":"Acute gastrointestinal haemorrhage in patients treated with anticoagulant drugs","volume":"36","author":"Choudari","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.blre.2015.03.004_bb0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0002-9343(87)90004-0","article-title":"Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy","volume":"82","author":"Landefeld","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1742-1241.2011.02809.x","article-title":"Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation","volume":"66","author":"Coleman","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.blre.2015.03.004_bb0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation","volume":"14","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0175","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","article-title":"The risk for and severity of bleeding complications in elderly patients treated with warfarin","volume":"124","author":"Fihn","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0180","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.110.007864","article-title":"Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for anticoagulation","volume":"124","author":"Poli","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2015.03.004_bb0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (BAFTA): a randomized controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.03.004_bb0190","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2015.03.004_bb0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5946\/ce.2012.45.2.138","article-title":"Non-steroidal anti-inflammatory drug-induced enteropathy","volume":"45","author":"Lim","year":"2012","journal-title":"Clin Endosc"},{"key":"10.1016\/j.blre.2015.03.004_bb0200","series-title":"Dabigatran etexilate","first-page":"1","article-title":"Boehringer Ingelheim","author":"FDA Advisory Committee Briefing Document","year":"2010"},{"key":"10.1016\/j.blre.2015.03.004_bb0205","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.blre.2015.03.004_bb0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.blre.2015.03.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.10.021","article-title":"Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial","volume":"11","author":"Bytzer","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.blre.2015.03.004_bb0225","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2013.11.013","article-title":"Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)","volume":"63","author":"Goodman","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.blre.2015.03.004_bb0230","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.jacc.2014.02.549","article-title":"Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes","volume":"63","author":"Hylek","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2015.03.004_bb0235","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1182\/blood-2007-11-123711","article-title":"Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based","volume":"111","author":"Levi","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2015.03.004_bb0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","article-title":"Cardiovascular, bleeding, and mortality risks in elderly medicare patients treated with dabigatran or warfarin for non-valvular atrial fibrillation","volume":"131","author":"Graham","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2015.03.004_bb0245","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","article-title":"Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies","volume":"52","author":"Garcia Rodriguez","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.blre.2015.03.004_bb0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3949\/ccjm.77a.09035","article-title":"Managing acute upper GI bleeding, preventing recurrences","volume":"77","author":"Albeldawi","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0255","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0260","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-147-8-200710160-00004","article-title":"Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial","volume":"147","author":"Glynn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0265","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes","volume":"307","author":"De Berardis","year":"2012","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.blre.2015.03.004_bb0270","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar4175","article-title":"Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage","volume":"15","author":"Sostres","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.blre.2015.03.004_bb0275","doi-asserted-by":"crossref","first-page":"762-768.e6","DOI":"10.1016\/j.cgh.2011.05.020","article-title":"Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis","volume":"9","author":"Lanas","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.blre.2015.03.004_bb0280","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0285","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2015.03.004_bb0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-150-6-200903170-00009","article-title":"Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force","volume":"150","author":"Wolff","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7015-4-22","article-title":"Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications","volume":"4","author":"Hern\u00e1ndez-D\u00edaz","year":"2006","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.blre.2015.03.004_bb0300","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.clinthera.2009.09.005","article-title":"A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding","volume":"31","author":"Hsiao","year":"2009","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.blre.2015.03.004_bb0305","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00535-013-0905-z","article-title":"Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis","volume":"49","author":"Yuhara","year":"2014","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.blre.2015.03.004_bb0310","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1053\/j.gastro.2011.02.004","article-title":"Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding","volume":"140","author":"Strate","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.blre.2015.03.004_bb0315","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apt.12483","article-title":"Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study","volume":"38","author":"Lin","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.blre.2015.03.004_bb0320","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"9706","key":"10.1016\/j.blre.2015.03.004_bb0325","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"S\u00f8rensen","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.blre.2015.03.004_bb0330","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.110.973008","article-title":"Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications","volume":"123","author":"Garc\u00eda Rodr\u00edguez","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.blre.2015.03.004_bb0335","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.blre.2015.03.004_bb0340","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/07853890.2011.582137","article-title":"Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention","volume":"43","author":"Di Minno","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.blre.2015.03.004_bb0345","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.blre.2015.03.004_bb0350","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2015.03.004_bb0355","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ijcard.2013.06.135","article-title":"Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial","volume":"168","author":"DiNicolantonio","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.blre.2015.03.004_bb0360","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1472-8206.2009.00710.x","article-title":"Aggressive chronic platelet inhibition with prasugrel and increased cancer risks: revising oral antiplatelet regimens?","volume":"23","author":"Serebruany","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"issue":"14","key":"10.1016\/j.blre.2015.03.004_bb0365","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","article-title":"Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial","volume":"54","author":"Nikolsky","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2015.03.004_bb0370","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehp110","article-title":"Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial","volume":"30","author":"Mehran","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.blre.2015.03.004_bb0375","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.blre.2015.03.004_bb0380","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"11; 116","author":"Spencer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2015.03.004_bb0385","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jth.12140","article-title":"Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary","volume":"11","author":"Lip","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.03.004_bb0390","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eur416","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.blre.2015.03.004_bb0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH11-12-0827","article-title":"The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER)","volume":"108","author":"Omran","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.03.004_bb0400","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4244\/EIJV8I6A105","article-title":"Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score","volume":"8","author":"Smith","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.blre.2015.03.004_bb0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.blre.2015.03.004_bb0410","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1538-7836.2008.03001.x","article-title":"Validation of a composite score for clinical severity of hemophilia","volume":"6","author":"Schulman","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"18","key":"10.1016\/j.blre.2015.03.004_bb0415","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood-2012-11-468207","article-title":"A specific antidote for dabigatran: functional and structural characterization","volume":"121","author":"Schiele","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2015.03.004_bb0420","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.3102","article-title":"A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa","volume":"19","author":"Lu","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.blre.2015.03.004_bb0425","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.dld.2013.11.005","article-title":"Time trends and outcome of gastrointestinal bleeding in the Veneto Region: a retrospective population based study from 2001 to 2010","volume":"46","author":"Cavallaro","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.blre.2015.03.004_bb0430","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.2010.04563.x","article-title":"The changing face of hospitalisation due to gastrointestinal bleeding and perforation","volume":"33","author":"Lanas","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.blre.2015.03.004_bb0435","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","article-title":"Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants","volume":"102","author":"Lanas","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.blre.2015.03.004_bb0440","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fphar.2010.00126","article-title":"Risk of upper gastrointestinal bleeding in a cohort of new users of low-dose aspirin for secondary prevention of cardiovascular outcomes","volume":"1","author":"Cea Soriano","year":"2010","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.blre.2015.03.004_bb0445","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.gastro.2011.03.049","article-title":"Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy","volume":"141","author":"Lin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.blre.2015.03.004_bb0450","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-152-2-201001190-00009","article-title":"International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding","volume":"152","author":"Barkun","year":"2010","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.blre.2015.03.004_bb0455","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.112.001233","article-title":"Genetic determinants of dabigatran plasma levels and their relation to bleeding","volume":"127","author":"Par\u00e9","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.blre.2015.03.004_bb0460","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1160\/TH11-08-0566","article-title":"Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation","volume":"107","author":"Salazar","year":"2012","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.blre.2015.03.004_bb0465","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/jcph.306","article-title":"Population pharmacokinetic-pharmacodynamic modeling analysis of intrinsic FXa and bleeding from edoxaban treatment","volume":"54","author":"Song","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.blre.2015.03.004_bb0470","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2337\/dc09-1297","article-title":"Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes","volume":"32","author":"Calvin","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.blre.2015.03.004_bb0475","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"44","key":"10.1016\/j.blre.2015.03.004_bb0480","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1093\/eurheartj\/eht058","article-title":"Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?","volume":"34","author":"Patrono","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.blre.2015.03.004_bb0485","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1160\/TH13-04-0326","article-title":"Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation","volume":"110","author":"Cea Soriano","year":"2013","journal-title":"Thromb Haemost"},{"issue":"381","key":"10.1016\/j.blre.2015.03.004_bb0490","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"30","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.03.004_bb0495","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1160\/TH11-08-0602","article-title":"Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe","volume":"106","author":"Huber","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.03.004_bb0500","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2036.1999.00470.x","article-title":"Protection of human gastric mucosa against aspirin-enteric coating or dose reduction?","volume":"13","author":"Cole","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"19","key":"10.1016\/j.blre.2015.03.004_bb0505","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin interruption for gastrointestinal bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch Intern Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T17:25:22Z","timestamp":1537723522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X15000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0268960X15000272"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2015.03.004","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}